A triad of costimulatory molecules synergize to amplify T-cell activation.

James W. Hodge(Center for Cancer Research), Jeffrey Schlom(National Cancer Institute), Michael G. Lorenz, Alicia Gómez Yafal, Linda Gritz, H Sabzevari

PubMed

November 15, 1999

Cited by 297

Related Papers

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

|The Journal of Experimental Medicine|2006|1.7k

Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

|Journal of Clinical Oncology|2010|973

Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide

|Blood|2005|896

Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

|Hybridoma|1984|580

A spectrum of monoclonal antibodies reactive with human mammary tumor cells.

|Proceedings of the National Academy of Sciences|1981|563